Stock bpth
BPTH stock rating and analysis - Bio-Path Holdings : a summary of key financial strength and profitability metrics. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 25.00, with a high estimate of 25.00 and 18 Feb 2020 (NASDAQ: BPTH) CEO Peter Nielsen. He and his board of directors have had to manage shareholders who have suffered a drop from a 52-week Learn about BPTH with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on BPTH. Stocks by Morningstar Classification Bio-Path Holdings stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The average Bio-Path Holdings stock price for the last 52 weeks is 11.52. Compare BPTH With Other Stocks
Get breaking news and analysis on Bio-Path Holdings, Inc. (BPTH) stock, price quote and chart, trading and investing tools.
Real-time trade and investing ideas on Bio-Path Holdings Inc. BPTH from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Shares of BPTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock (Launch) Jan 15 2019 Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook BPTH Stock analysis for Bio-Path Holdings Inc (BPTH:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
View BPTH stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst.
Find the latest Bio-Path Holdings, Inc. (BPTH) stock quote, history, news and other vital information to help you with your stock trading and investing. Bio-Path Holdings Inc. BPTH 3.15 0.49 (13.05%). NASDAQUpdated Mar 16, 2020 9:38 PM. 14,899. Watchers. Watch. Filter by: Real-Time. 0 New Post. BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview. Bio-Path Holdings, Inc. Common Stock (BPTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View live BIO-PATH HOLDINGS INC chart to track its stock's price action. Find market predictions, BPTH financials and market news.
Get breaking news and analysis on Bio-Path Holdings, Inc. (BPTH) stock, price quote and chart, trading and investing tools.
BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, Bio-Path Holdings, Inc. Common Stock (BPTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View Bio-Path Holdings, Inc. BPTH investment & stock information. Get the latest Bio-Path Holdings, Inc. BPTH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Real time Bio-Path Holdings (BPTH) stock price quote, stock graph, news & analysis. Real time Bio-Path Holdings (BPTH) stock price quote, stock graph, news & analysis.
BPTH | Complete Bio-Path Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
18 Feb 2020 (NASDAQ: BPTH) CEO Peter Nielsen. He and his board of directors have had to manage shareholders who have suffered a drop from a 52-week Learn about BPTH with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on BPTH. Stocks by Morningstar Classification Bio-Path Holdings stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The average Bio-Path Holdings stock price for the last 52 weeks is 11.52. Compare BPTH With Other Stocks BPTH: Get the latest Bio-Path stock price and detailed information including BPTH news, historical charts and realtime prices. 15 Nov 2019 Bio-Path (BTPH) earnings for the biotechnology company's third quarter of 2019 saw BPTH stock taking a wild ride on Friday. Current Technical Analysis and interactive chart for $BPTH stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.
15 Nov 2019 Bio-Path (BTPH) earnings for the biotechnology company's third quarter of 2019 saw BPTH stock taking a wild ride on Friday. Current Technical Analysis and interactive chart for $BPTH stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. View BPTH stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst. Ratings Calendar · Stock Split Calendar · Ratings · Analyst Comments · Hot Analyst Comments · Analyst EPS Change · Analyst EPS View · Analyst PT Change Bio-Path Holdings, I. BPTH. Delayed Nasdaq - 02/28 04:00:00 pm. 5.48USD. - 0.36% View the real-time BPTH price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying BPTH. Bio-Path Holdings. $5.35 /. +0.85 (+18.89%). Bio-Path Holdings… in a registered direct offering of 808,080 shares of its common stock and warrants to